Xenbase is undergoing scheduled maintenance Wednesday, June 14 and Thursday, June 15, 2023. Xenbase will be unavailable on those days.

 Click on this message to dismiss it.
Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-25575

Xla Wt + rmnd5a MO, Hantel F et al. (2022)

Experiment + Assay: Xla Wt + rmnd5a MO + NF17 (whole-mount microscopy)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rmnd5a MO1 rmnd5a (Xla)
 NF stage 2 (2-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
whole-mount microscopy NF stage 17 to NF stage 17  
Anatomical Phenotypes: abnormal optic vesicle , decreased size of the optic vesicle
Source: Fig.7.Ab
Article: XB-ART-59107, PubMed